Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Arrowhead Pharmaceuticals to Participate in Upcoming March 2020 Conferences

Abstract:
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

Arrowhead Pharmaceuticals to Participate in Upcoming March 2020 Conferences

Pasadena. CA | Posted on March 3rd, 2020

Barclays Global Healthcare Conference– Miami, March 10-12, 2020

March 11, 11:15 a.m. ET – Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will participate in a hybrid podium/fireside chat presentation

5th Annual Oligonucleotide & Precision Therapeutics Congress– Cambridge, MA, March 16-19, 2020

March 17, 2:00 p.m. ET – Mark Yen, M.D., Arrowhead’s director of clinical development, will deliver an oral presentation titled, “Arrowhead TRiM Platform in the Clinic”

Oppenheimer 30th Annual Healthcare Conference – New York, March 17-18, 2020

March 18, 3:55 p.m. ET – Bruce Given will participate in a fireside chat presentation

A copy of the presentation materials and webcast links, if the presentation is being webcast, may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.

####

About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadpharma.com/email-alerts .

Safe Harbor Statement under the Private Securities Litigation Reform Act:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the safety and efficacy of our product candidates, the duration and impact of regulatory delays in our clinical programs, our ability to finance our operations, the likelihood and timing of the receipt of future milestone and licensing fees, the future success of our scientific studies, our ability to successfully develop and commercialize drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, and the enforcement of our intellectual property rights. Our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.

For more information, please click here

Contacts:
Arrowhead Pharmaceuticals, Inc.
Vince Anzalone, CFA
626-304-3400


Investors and Media:
LifeSci Advisors, LLC
Brian Ritchie
212-915-2578

www.lifesciadvisors.com

Copyright © Arrowhead Pharmaceuticals, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

The lightest shielding material in the world: Protection against electromagnetic interference July 3rd, 2020

Spintronics: Faster data processing through ultrashort electric pulses July 3rd, 2020

A path to new nanofluidic devices applying spintronics technology: Substantial increase in the energy conversion efficiency of hydrodynamic power generation via spin currents July 3rd, 2020

Towards lasers powerful enough to investigate a new kind of physics: An international team of researchers has demonstrated an innovative technique for increasing the intensity of lasers July 3rd, 2020

Possible Futures

Spintronics: Faster data processing through ultrashort electric pulses July 3rd, 2020

A path to new nanofluidic devices applying spintronics technology: Substantial increase in the energy conversion efficiency of hydrodynamic power generation via spin currents July 3rd, 2020

Towards lasers powerful enough to investigate a new kind of physics: An international team of researchers has demonstrated an innovative technique for increasing the intensity of lasers July 3rd, 2020

Crystal structure discovered almost 200 years ago could hold key to solar cell revolution July 3rd, 2020

Investments/IPO's/Splits

180 Degree Capital Corp. Reports Q1 2020 Results and Developments From Q2 2020 May 6th, 2020

180 Degree Capital Corp. Selected to Manage $25 Million by Pension Fund May 6th, 2020

180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020

Arrowhead Pharmaceuticals to Participate in Upcoming May 2020 Conferences May 1st, 2020

Nanomedicine

Charcoal a weapon to fight superoxide-induced disease, injury: Nanomaterials soak up radicals, could aid treatment of COVID-19 July 2nd, 2020

Cellulose for manufacturing advanced materials: A review of the scientific literature made at the University of the Basque Country (UPV/EHU) highlights the potential of hybrid materials based on cellulose nanocrystals June 26th, 2020

Wearable patch may provide new treatment option for skin cancer June 18th, 2020

Tiny pump builds polyrotaxanes with precision: Artificial molecular pump gives precise control for materials design June 12th, 2020

Announcements

Towards lasers powerful enough to investigate a new kind of physics: An international team of researchers has demonstrated an innovative technique for increasing the intensity of lasers July 3rd, 2020

Crystal structure discovered almost 200 years ago could hold key to solar cell revolution July 3rd, 2020

Flexible material shows potential for use in fabrics to heat, cool July 3rd, 2020

Carbon-loving materials designed to reduce industrial emissions July 3rd, 2020

Events/Classes

Arrowhead Pharmaceuticals to Participate in Upcoming May 2020 Conferences May 1st, 2020

The National Space Society not holding the International Space Development Conference 2020 in May Due to COVID-19 Concerns March 19th, 2020

Global Summit on Material Science and Nanotechnology March 5th, 2020

National Space Society to Honor NASA's Juno Mission Team at Its 2020 International Space Development Conference: Dr. Scott Bolton, Juno Mission Principal Investigator, to Accept February 28th, 2020

Nanobiotechnology

Charcoal a weapon to fight superoxide-induced disease, injury: Nanomaterials soak up radicals, could aid treatment of COVID-19 July 2nd, 2020

Cellulose for manufacturing advanced materials: A review of the scientific literature made at the University of the Basque Country (UPV/EHU) highlights the potential of hybrid materials based on cellulose nanocrystals June 26th, 2020

Wearable patch may provide new treatment option for skin cancer June 18th, 2020

Prodigiosin-based solution has selective activity against cancer cells: A new nanoformulation was described by Kazan University's Bionanotechnology Lab in Frontiers in Bioengineering and Biotechnology June 12th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project